Pharmacological investigations of the unique herbal formula Menoprogen in rats: Estrogenic activity and mechanism

References

• Kupperman H S, Wetchler B B, Blatt M HG. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol 1953; 13: 688
   PubMed Web of Science ®Google Scholar
• Heckbert S R, Kaplan R C, Weiss N S, Psaty B M, Lin D, Furberg C D, Starr J R, Anderson G D, LaCroix A Z. Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. Arch Intern Med 2001; 161: 1709–1713
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998; 280: 605–613
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L, Jackson R D, Beresford S A, Howard B V, Johnson K C, Kotchen J M, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2003; 288: 321–333
   Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350: 1047–1059
   PubMed Web of Science ®Google Scholar
• Rodrigues C, Patel A V, Calle E E, Jacob E J, Thun M J. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. J Am Med Assoc 2001; 285: 1460–1465
   Google Scholar
• United States Preventive Services Task Force. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med 2002; 137: 834–839
   PubMedGoogle Scholar
• M Blumenthal, Busse, W R, Goldberg, A. German Commission E monographs: Therapeutics monographs on medicinal plants for human use, Klein S, Rister RS, translators. Austin, TX, American Botanical Council. 1998
   Google Scholar
• Taylor M. Nonhormonal alternatives for the menopause syndrome. Infertil Reprod Med Clin North Am 2001; 12: 669–685
   Google Scholar
• Vincent A, Fitzpatrick L A. Soy isoflavones: are they useful in menopause?. Mayo Clin Proc 2000; 75: 1174–1184
   PubMed Web of Science ®Google Scholar
• Davis S. Phytoestrogen therapy for menopausal symptoms?. Br Med J 2001; 323: 354–355
   PubMedGoogle Scholar
• Van Patten C L, Olivotto I A, Chambers G K, Gelmon K A, Hislop T G, Templeton E, Wattie A, Prior J C. Effects of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trials. J Clin Oncol 2002; 20: 1449–1455
   PubMed Web of Science ®Google Scholar
• McMichael-Phillips D F, Harding C, Morton M, Roberts S A, Howell A, Potten C S, Bundred N J. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998; 68: 1431S–1436S
   PubMed Web of Science ®Google Scholar
• Allred C D, Allred K F, Ju Y H, Virant S M, Helferich W G. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 2001; 61: 5054–5050
   Google Scholar
• Ju Y H, Allred C D, Allred K F, Karko K L, Doerge D R, Helferich W G. Physiological concentrations of dietary genistein dose dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr 2001; 131: 2957–2962
   PubMed Web of Science ®Google Scholar
• This P, De la Rochefordiere A, Clough K, Fourquet A, Magdelenat H, Breast Cancer Group of the Institut Curie. Phytoestrogens after breast cancer. Endocr Relat Cancer 2001; 8: 129–134
   PubMed Web of Science ®Google Scholar
• Diel P, Smolnikar K, Schulz T, Laudenbach-Leschowski U, Michna H, Vollmer G. Phytoestrogens and carcinogenesis – differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum Reprod 2001; 16: 997–1006
   PubMed Web of Science ®Google Scholar
• Rao R V, Hermel E, Castro-Obregon S, del Rio G, Ellerby L M, Ellerby H M, Bredesen D E. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem 2001; 276: 33869–33874
   PubMed Web of Science ®Google Scholar
• Nakamura K, Bossy-Wetzel E, Burns K, Fadel M P, Lozyk M, Goping I S, Opas M, Bleackley R C, Green D R, Michalak M. Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis. J Cell Biol 2000; 150: 731–740
   PubMed Web of Science ®Google Scholar
• Martinou J C, Desagher S, Antonsson B. Cytochrome c release from mitochondria: all or nothing. Nat Cell Biol 2000; 2: E41–E43
   PubMed Web of Science ®Google Scholar
• Shi X L. Human genesiology. Academia Press, Beijing 2002; 359
   Google Scholar